Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2025-12-24 @ 11:16 PM
NCT ID: NCT05068856
Eligibility Criteria: Inclusion Criteria: 1. 18-70 years of age, both male and female 2. non standard treatment, invalid the standard treatment or refuse to receive standard treatment in patients with advanced tumors diagnosed by pathology 3. the Eastern Cooperative Oncology Group (ECOG) General status (performance status, PS) of 0-1 4. the expected lifetime ≥ 3 months 5. Has at least one measurable lesion as defined by RECIST v1.1 6. Written informed consent is provided by signing the informed consent form Exclusion Criteria: 1. Any previous anti-tumor treatment 2. The toxicity caused by any previous anti-tumor treatment has not recovered to ≤ grade 1 3. Any other anti-tumor treatment is planned during the study treatment 4. After imaging diagnosis, there were brain tumor lesions 5. According to the judgment of the researcher, there are factors that can not swallow, chronic diarrhea and intestinal obstruction or other factors that can significantly affect the absorption, distribution, metabolism or excretion of drugs 6. Active heart disease was present within 6 months before the first administration of the study 7. Other malignancies occurred within 5 years before the first administration of the study 8. Active HBV or HCV infection 9. The subject had a history of immune deficiency 10. According to the judgment of the researcher, there are concomitant diseases that seriously endanger the safety of the subjects, confuse the analysis of the test results, or affect the subjects to complete the study
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 70 Years
Study: NCT05068856
Study Brief:
Protocol Section: NCT05068856